Marc Penn
Oprichter bij Cleveland HeartLab, Inc.
Profiel
Marc S.
Penn is the founder of Juventas Therapeutics, Inc. (founded in 2007), Cleveland HeartLab, Inc. (founded in 2009), and SironRX Therapeutics, Inc. (founded in 2010).
He held the position of Director & Chief Medical Officer at Juventas Therapeutics, Inc. from 2013 to 2014, Chief Medical Officer at Cleveland HeartLab, Inc. from 2009 to present, and Chief Medical Officer at SironRX Therapeutics, Inc. from 2010 to 2014.
Dr. Penn currently holds the position of Director & Chief Medical Officer at Diasome Pharmaceuticals, Inc., Director at Rhythm Therapeutics, Inc., Research Director at Summa Health System (Ohio), Director at SnappSkin, Inc., Chief Marketing Officer & Director at Keystone Bio, Inc., and Professor at Northeast Ohio Medical University.
He previously held the position of Director at Cardiovip, Inc. from 2012 to 2014, Venture Partner at Oakwood Medical Investors, Clinical Partner at Foundation Medical Partners from 2009 to 2011, Chief Medical Officer at PrognostiX, Inc., and Chief Medical Officer at Kenwood Health Group.
Dr. Penn received his doctorate degree from Case Western Reserve University in 1994 and 1989, and his undergraduate and graduate degrees from Case Western Reserve University.
Actieve functies van Marc Penn
| Bedrijven | Functie | Begin |
|---|---|---|
Cleveland HeartLab, Inc.
 Cleveland HeartLab, Inc. Medical/Nursing ServicesHealth Services Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH. | Oprichter | 01-01-2009 |
Summa Health System (Ohio)
 Summa Health System (Ohio) Hospital/Nursing ManagementHealth Services Summa Health System, Inc. provides integrated and coordinated care services. It offers medical, specialized, support, and testing services. The company was founded in 1989 and is headquartered in Akron, OH. | Hoofd Techniek/Wetenschap/O&O | - |
| Northeast Ohio Medical University | Corporate Officer/Principal | - |
| SnappSkin, Inc. | Directeur/Bestuurslid | - |
| Rhythm Therapeutics, Inc. | Directeur/Bestuurslid | - |
Diasome Pharmaceuticals, Inc.
 Diasome Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diasome Pharmaceuticals, Inc. operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes. It focuses on the clinical and commercial development of breakthrough therapies for diabetes and obesity. The company’s technology platform is based on the use of its proprietary Hepatocyte Directed Vesicle or HDV, nanotechnology to deliver a wide range of critically necessary hormones and drugs to the liver, the body’s primary site of glucose storage. The firm’s HDV system is designed to fundamentally improve the way in which insulin works in people with diabetes by enabling much greater amounts of injected insulin to reach hepatocytes, the liver’s glucose storing cells. The company was founded by Len Rosenberg, Lance Converse, W. Blair Geho and Robert Geho in 2004 and is headquartered in Cleveland, OH. | Hoofd Techniek/Wetenschap/O&O | - |
Keystone Bio, Inc.
 Keystone Bio, Inc. BiotechnologyHealth Technology Keystone Bio, Inc. engages in operation PharmaBiome biotech company. It develops pathogen of chronic inflammation that is shown to initiate and advance Atherosclerosis, heart disease, and Alzheimer's disease. The company is headquartered in St. Louis, MO. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Marc Penn
| Bedrijven | Functie | Einde |
|---|---|---|
| Cardiovip, Inc. | Directeur/Bestuurslid | 01-01-2014 |
Foundation Medical Partners
 Foundation Medical Partners Investment ManagersFinance Founded in 2001, Foundation Medical Partners is a venture capital firm located in Rowayton, Connecticut. The firm is affiliated with the Cleveland Clinic | Private Equity Investor | - |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Opleiding van Marc Penn
| Case Western Reserve University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
Oakwood Medical Investors
 Oakwood Medical Investors Investment ManagersFinance Oakwood Medical Investors (Oakwood Medical Investors) is a venture capital firm founded in 1997 by Raul Perez. The firm is headquartered in Louis, Missouri. | Finance |
PrognostiX, Inc.
 PrognostiX, Inc. Pharmaceuticals: MajorHealth Technology PrognostiX, Inc. discovers and develops biomarker technologies. The firm also offers cardiovascular and inflammatory biomarkers. The company was founded in 2004 and is headquartered in Cleveland, OH. | Health Technology |
Foundation Medical Partners
Foundation Medical Partners Investment ManagersFinance Founded in 2001, Foundation Medical Partners is a venture capital firm located in Rowayton, Connecticut. The firm is affiliated with the Cleveland Clinic | Finance |
Cleveland HeartLab, Inc.
Cleveland HeartLab, Inc. Medical/Nursing ServicesHealth Services Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH. | Health Services |
Juventas Therapeutics, Inc.
 Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Juventas Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. It is a clinical-stage biotechnology company developing a pipeline of factor-based regenerative therapies to treat life-threatening diseases. The company's product has been shown to protect and repair tissue following ischemic injury by recruiting the body's own stem cells to the damaged tissue. The company was founded by Rahul A. Aras and Marc S. Penn in 2007 and is headquartered in Cleveland, OH. | Health Services |
SironRX Therapeutics, Inc.
 SironRX Therapeutics, Inc. Hospital/Nursing ManagementHealth Services SironRX Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. Its technology is stromal cell-derived factor-1 is a naturally occurring chemokine that is rapidly over-expressed in response to tissue injury, particularly during ischemia. The firm is developing novel therapies that promote wound repair and prevent scarring of dermal wounds. The company was founded by Marc S. Penn and Rahul Aras in 2010 and is headquartered in Cleveland, OH. | Health Services |
Summa Health System (Ohio)
Summa Health System (Ohio) Hospital/Nursing ManagementHealth Services Summa Health System, Inc. provides integrated and coordinated care services. It offers medical, specialized, support, and testing services. The company was founded in 1989 and is headquartered in Akron, OH. | Health Services |
| Kenwood Health Group | |
| Cardiovip, Inc. | |
| SnappSkin, Inc. | Miscellaneous |
| Rhythm Therapeutics, Inc. | Health Technology |
Diasome Pharmaceuticals, Inc.
Diasome Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diasome Pharmaceuticals, Inc. operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes. It focuses on the clinical and commercial development of breakthrough therapies for diabetes and obesity. The company’s technology platform is based on the use of its proprietary Hepatocyte Directed Vesicle or HDV, nanotechnology to deliver a wide range of critically necessary hormones and drugs to the liver, the body’s primary site of glucose storage. The firm’s HDV system is designed to fundamentally improve the way in which insulin works in people with diabetes by enabling much greater amounts of injected insulin to reach hepatocytes, the liver’s glucose storing cells. The company was founded by Len Rosenberg, Lance Converse, W. Blair Geho and Robert Geho in 2004 and is headquartered in Cleveland, OH. | Health Technology |
Keystone Bio, Inc.
Keystone Bio, Inc. BiotechnologyHealth Technology Keystone Bio, Inc. engages in operation PharmaBiome biotech company. It develops pathogen of chronic inflammation that is shown to initiate and advance Atherosclerosis, heart disease, and Alzheimer's disease. The company is headquartered in St. Louis, MO. | Health Technology |